has acquired

Duff & Phelps, A Kroll Business, Advised Swedish Bio Convergence Company CELLINK on the Acquisition of U.S. Microscopy Trailblazer Discover Echo

Contact Us

On June 2021, CELLINK AB (“CELLINK”) entered into an agreement to acquire Discover Echo Inc. (“Discover Echo”), an innovative and revolutionary American company focusing on development, manufacturing, and sales of patented and unique hybrid microscopes that easily transform between Upright and Inverted configurations, merging the capabilities of multiple instruments into one.

Duff & Phelps, A Kroll Business, acted as the financial advisor  to CELLINK and provided financial and tax due diligence in connection with the acquisition.

About CELLINK
Founded in 2016, CELLINK is a leading bioconvergence company that provides technologies, products, and services to create, understand and master biology. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. CELLINK’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,700 publications. CELLINK is creating the future of medicine. CELLINK is listed on the Nasdaq Stockholm under CLNK B.

About Discover Echo
Discover Echo, founded in 2013 and headquartered in San Diego, is a fast-growing microscopy and imaging company with around 50 employees. The company serves customers mainly in North America, but has gained a strong presence in Europe and Asia and has a European subsidiary in the UK.

2021-08-04T00:00:00.0000000 /-/media/assets/images/transactions/2021/cellink-life-sciences.png /-/media/assets/images/transactions/2021/echo.png /about-us/transactions/m-and-a/financial-advisor-cellink-echo case study {D59CA77E-C551-45A3-BE89-F567210C5A60} {4DACD310-421A-42AC-BEF4-8AA7E70484CD} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {13E28841-C245-441D-8C3B-49E72DA5381C} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {DF0A8D82-EB98-4261-8951-BF842E034FA8} {B871D4F9-5FCB-40B9-8710-871A30B710AB}

Other Areas We Can Help

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior deal execution.

M&A Advisory
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group
Private Capital Markets

Private Capital Markets

Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.

Private Capital Markets

Related Case Studies

Insights

M&A Advisory

China Transactions Insights – Fall 2021

M&A Advisory
Transaction Advisory

Is There an Investment Opportunity for “Bad” ESG Assets?

Transaction Advisory
M&A Advisory

Diagnostic Imaging Equipment Services Update – Summer 2021

M&A Advisory
Valuation

The Coming of Age of Private Credit in India

Valuation

News